TOWARDS A UNIVERSAL MODEL REGULATORY FRAMEWORK FOR DERIVATIVES: POST-CRISIS CONCLUSIONS FROM THE UNITED STATES AND THE EUROPEAN UNION

被引：0
|
作者：
Garslian, Levon
机构：
来源：
UNIVERSITY OF PENNSYLVANIA JOURNAL OF INTERNATIONAL LAW | 2016年 / 37卷 / 03期
关键词：
SEC;
D O I：
暂无
中图分类号：
D9 [法律]; DF [法律];
学科分类号：
0301 ;
摘要：
引用
收藏
页码：941 / +
页数：88
相关论文
共 8 条
  • [1] The Potential Relevance to the United States of the European Union's Newly Adopted Regulatory Framework for Telecommunications
    Marcus, J. Scott
    RETHINKING RIGHTS AND REGULATIONS: INSTITUTIONAL RESPONSES TO NEW COMMUNICATIONS TECHNOLOGIES, 2003, : 397 - 428
  • [2] The Post September 11 Global Security Agenda: A Comparative Analysis of United States and European Union Policies Towards Africa
    Olsen, Gorm Rye
    INTERNATIONAL POLITICS, 2008, 45 (04) : 457 - 474
  • [3] The Post September 11 Global Security Agenda: A Comparative Analysis of United States and European Union Policies Towards Africa
    Gorm Rye Olsen
    International Politics, 2008, 45 : 457 - 474
  • [4] Post-approval quality-related regulatory actions for biopharmaceuticals approved in the European Union and the United States between 1995 and 2019
    Alsamil, Ali M.
    Gardarsdottir, Helga
    Leufkens, Hubert G.
    Egberts, Toine C.
    Giezen, Thijs J.
    DRUG DISCOVERY TODAY, 2023, 28 (10)
  • [5] Regulatory Lessons for Internet Traffic Management from Japan, the European Union, and the United States: Toward Equity, Neutrality, and Transparency
    Stevenson, John Harris
    Clement, Andrew
    GLOBAL MEDIA JOURNAL-CANADIAN EDITION, 2010, 3 (01): : 9 - 29
  • [6] Post-marketing surveillance framework of cell and gene therapy products in the European Union, the United States, Japan, South Korea and China: a comparative study
    Yuxin Cai
    Lijuan Sui
    Jingjing Wang
    Weilin Qian
    Yeheng Peng
    Luyao Gong
    Weijia Wu
    Yuan Gao
    BMC Medicine, 22 (1)
  • [7] Model-based comparisons of post-treatment free IgE and FEV1 between omalizumab asthma dosing tables in the United States and European Union
    Zhu, Rui
    Schoemaker, Rik
    Gautier, Aurelie
    Tian, Xianbin
    Sim, Cheryl HooiMing
    Omachi, Theodore A.
    Joshi, Amita
    Jin, Jin
    Owen, Ryan
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024,
  • [8] Characteristics of Single Pivotal Trials Supporting Regulatory Approvals of Novel Non-orphan, Non-oncology Drugs in the European Union and United States from 2012-2016
    Morant, Anne Vinther
    Jagalski, Vivien
    Vestergaard, Henrik Tang
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2019, 12 (04): : 361 - 370
1